Healthcare Stocks Cardiol Therapeutics’ Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association Results demonstrate CardiolRx™ may represent a paradigm shift in the treatment of… Ryan AllwayMay 7, 2026
Feature Healthcare Stocks Top News Monte Rosa’s Big Raise Shows Why Anti-Inflammatory Stories Are in Focus Eli Lilly’s buyout of Ventyx Biosciences (Nasdaq: VTYX) signaled that Big Pharma… Robin LeffertsJanuary 28, 2026
Feature Healthcare Stocks Top News A Close Look at Cardiol Therapeutics’ Phase 2 Results Shows the Path Forward Not all clinical trial results are cut and dried. Sometimes the outcome… Robin LeffertsDecember 9, 2025
Feature Healthcare Stocks Top News Cardiol Therapeutics’ Financing Paves Way for Heart Failure Drug Development Smaller pharmaceutical companies embark on an exciting journey as they seek to… Robin LeffertsOctober 29, 2025
Feature Healthcare Stocks Top News Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx™ in Acute Myocarditis Toronto, Ontario–(Newsfile Corp. – August 6, 2025) – Cardiol Therapeutics Inc. (NASDAQ: CRDL)… Ryan AllwayAugust 6, 2025
Feature Healthcare Stocks Former Eli Lilly CMO Joins Cardiol’s Board, Bolstering Drug Development, Clinical Trial, and Commercial Expertise As smaller clinical stage pharmaceutical companies advance drug candidates from the lab… Robin LeffertsMay 29, 2025
Healthcare Stocks Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors Former Chief Medical Officer of Eli Lilly brings more than thirty years… Ryan AllwayApril 29, 2025
Feature Healthcare Stocks The Growing Market for Recurrent Pericarditis Therapies Recurrent pericarditis management has evolved significantly in recent years, with treatment approaches… Robin LeffertsApril 16, 2025
Feature Healthcare Stocks From $1 to $8? Why Analyst Experts Are Bullish on Cardiol Sometimes stock market performance doesn’t line up with the fundamentals of a… Robin LeffertsApril 1, 2025
Feature Healthcare Stocks Small Pharma, Big Gains: The Power of Clinical Trial Results For smaller pharmaceutical companies, valuation can be greatly impacted by progression in… Robin LeffertsMarch 13, 2025
